Literature DB >> 18665368

Studies of RET gene expression and acetylcholinesterase activity in a series of sporadic Hirschsprung's disease.

Maria Cecília M Coelho1, Uenis Tannuri, Israel Benditt, Maria Merces Santos.   

Abstract

The purpose is to present the studies of RET gene expression and acetylcholinesterase activity in 23 patients operated for Hirschsprung's disease (HD). The patients underwent either transanal endorectal pull-through or Duhamell's procedure. Full-thickness intestinal samples from the three different segments (ganglionic, intermediate and aganglionic) were collected. Each tissue sample was divided in two portions, one for AChE histochemical staining and the other for examination of RET mRNA expression level. All patients had an uneventful postoperative recovery. In all patients, the AChE stainings demonstrated the absence of activity in the ganglionic area, the marked increase of positive fibers in the aganglionic area, and little increase of positive fibers in the intermediate area. In the ganglionic and intermediate areas, all patients (100%) showed significant RET gene expression. In the aganglionic area, 18 patients (78.3%) did not present gene expression and the other five patients (21.7%) presented gene expression that was similar to the ganglionic and intermediate areas. The results reinforce the conclusion that the method of AChE staining is effective for the diagnosis of intestinal aganglionosis and confirm the knowledge that genes beyond RET may be implicated in the genesis of sporadic cases of HD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665368     DOI: 10.1007/s00383-008-2207-8

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  24 in total

Review 1.  RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.

Authors:  Naoya Asai; Mayumi Jijiwa; Atsushi Enomoto; Kumi Kawai; Kengo Maeda; Masatoshi Ichiahara; Yoshiki Murakumo; Masahide Takahashi
Journal:  Pathol Int       Date:  2006-04       Impact factor: 2.534

2.  Characterization of a multicomponent receptor for GDNF.

Authors:  J J Treanor; L Goodman; F de Sauvage; D M Stone; K T Poulsen; C D Beck; C Gray; M P Armanini; R A Pollock; F Hefti; H S Phillips; A Goddard; M W Moore; A Buj-Bello; A M Davies; N Asai; M Takahashi; R Vandlen; C E Henderson; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

3.  Study of acetylcholinesterase activity in rectal suction biopsy for diagnosis of intestinal dysganglionoses: 17-year experience of a single center.

Authors:  Maria Mercês Santos; Uenis Tannuri; Maria Cecília M Coelho
Journal:  Pediatr Surg Int       Date:  2008-04-12       Impact factor: 1.827

Review 4.  RET receptor tyrosine kinase gene mutations: molecular biological, physiological and clinical aspects.

Authors:  J W Höppener; C J Lips
Journal:  Eur J Clin Invest       Date:  1996-08       Impact factor: 4.686

5.  Altered RET gene mRNA expression in Hirschsprung's disease.

Authors:  T Kusafuka; P Puri
Journal:  J Pediatr Surg       Date:  1997-04       Impact factor: 2.545

6.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

7.  Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.

Authors:  M Angrist; S Bolk; M Halushka; P A Lapchak; A Chakravarti
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

8.  Germline mutation of the RET proto-oncogene in children with total intestinal aganglionosis.

Authors:  T Shimotake; N Iwai; K Inoue; T Kimura; D Ichikawa; T Abe; J Inazawa
Journal:  J Pediatr Surg       Date:  1997-03       Impact factor: 2.545

Review 9.  [The role of ret gene in the pathogenesis of Hirschsprung disease].

Authors:  Robert Smigiel; Dariusz Patkowski; Ryszard Slezak; Jerzy Czernik; Maria Sasiadek
Journal:  Med Wieku Rozwoj       Date:  2004 Jul-Sep

10.  Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease.

Authors:  T Attié; A Pelet; P Edery; C Eng; L M Mulligan; J Amiel; L Boutrand; C Beldjord; C Nihoul-Fékété; A Munnich
Journal:  Hum Mol Genet       Date:  1995-08       Impact factor: 6.150

View more
  1 in total

Review 1.  RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family.

Authors:  Elisangela P S Quedas; Viviane C Longuini; Tomoko Sekiya; Flavia L Coutinho; Sergio P A Toledo; Uenis Tannuri; Rodrigo A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.